Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126226682 | 12622668 | 2 | F | 20160803 | 20160804 | 20160805 | EXP | IT-JNJFOC-20160722357 | JANSSEN | BRAMBILLA A, CAPUTO R, CIMAZ R, SIMONINI G. CANAKINUMAB FOR CHILDHOOD SIGHT-THREATENING REFRACTORY UVEITIS: A CASE SERIES. J RHEUMATOL JUL-2016;43 (7):1445-1447. | 9.00 | YR | C | F | Y | 0.00000 | 20160805 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126226682 | 12622668 | 1 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 5 | MG/KG | LYOPHILIZED POWDER | |||||||
| 126226682 | 12622668 | 2 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 103772 | 5 | MG/KG | LYOPHILIZED POWDER | |||||||
| 126226682 | 12622668 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | DOSE: 15 MG PER M2 PER WEEK | 0 | UNSPECIFIED | |||||||||
| 126226682 | 12622668 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | DOSE: 15 MG PER M2 PER WEEK | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126226682 | 12622668 | 1 | Uveitis |
| 126226682 | 12622668 | 2 | Juvenile idiopathic arthritis |
| 126226682 | 12622668 | 3 | Juvenile idiopathic arthritis |
| 126226682 | 12622668 | 4 | Uveitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126226682 | 12622668 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126226682 | 12622668 | Drug hypersensitivity | |
| 126226682 | 12622668 | Off label use | |
| 126226682 | 12622668 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |